Navigation Links
Justice Department Requires Divestitures in Pearson's Acquisition of Harcourt Assessment
Date:1/24/2008

Divestitures Will Preserve Competition in Three Clinical Testing Markets

WASHINGTON, Jan. 24 /PRNewswire-USNewswire/ -- The Department of Justice said today that it will require Pearson Plc to divest assets relating to three clinical testing markets in order to proceed with Pearson's proposed $950 million acquisition of Harcourt Assessment. The Department said that the transaction, as originally proposed, would have resulted in higher prices to purchasers of clinical tests, including many school districts, and would likely have impaired the launch of a competitive new test for adult abnormal personality disorders. The products to be divested are clinical tests that are used by psychologists, speech-language pathologists, and clinicians to diagnose persons who have or are at risk of developing certain disorders or disabilities.

The Department's Antitrust Division filed a civil antitrust lawsuit today in U.S. District Court in Washington, D.C. to block the proposed acquisition. At the same time, the Division filed a proposed settlement that, if approved by the court, would resolve the lawsuit and the Department's competitive concerns.

The Department concluded that the transaction would have eliminated competition between Pearson and Harcourt and likely would have led to higher prices and reduced innovation for adaptive behavior and speech and language clinical tests. The merging parties are two of only a few firms that supply such tests. The Department also concluded that the proposed merger would have prevented Harcourt's planned entry as an independent competitor in the market for adult abnormal personality clinical tests, which likely would have resulted in a decline in prices and greater innovation for such tests.

"Without the divestitures obtained by the Department, purchasers of clinical tests for adaptive behavior, speech and language, and adult abnormal personality likely would have faced higher prices and reduced inn
'/>"/>

SOURCE U.S. Department of Justice
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Statement from AAJ President Kathleen Flynn Peterson on ATRAs Latest Attack on Civil Justice Attorneys
2. Miscarriage of Justice: A Statement by Judie Brown of the American Life League
3. NHCAA Presents 2007 Fraud Investigation of the Year Award to U.S. Departments of Justice, HHS, and Treasury for Convicting Internet Pharmacy Drug Kingpin
4. Drugs and Injustice
5. Written Statement of Kevin J. OConnor, Chairman of the Department of Justice Task Force on Intellectual Property, at the Senate Judiciary Committee Hearing on Intellectual Property Enforcement
6. Social Justice Issues Take Main Stage at Egypts National Democratic Party Convention
7. Susan G. Komen For The Cure, Karmanos Cancer Institute, Local Hospitals Call on Policymakers to Address Injustice and Unfairness in Breast Cancer Incidence and Mortality
8. Center for Health Justice Statement on Governors Veto of AB 1334
9. Department of Justice Awards $59M Task Order to SRA
10. Stryker Announces Resolution Related to March 2005 U.S. Department of Justice Subpoena
11. Civil Rights and Medical Leaders Call for Social Justice in Health Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...Colo., Nov. 21 Heska Cor...l present at the New York Society of,Security Ana...nference on,December 2, 2008 at 1177 Avenue of th...tation is scheduled to begin at 9:35 a.m. Eastern ...ble via live webcast and for two weeks,following ...
(Date:11/21/2008)...chers remain cautious about future antibiotic resi... Nov. 21 (HealthDay News) -- People with moderate ...OPD) may be able to reduce the frequency of exacer...tibiotic, a new report says. , The study, publ...ican Journal of Respiratory and Critical Care Medi...
(Date:11/21/2008)...ov. 21 The University ...beginning of a collaborative effort to eradicate b... Breast Cancer Awareness and Research of the Ameri...ady of the United States, and Vivian Fernandez de ...ning M. D. Anderson in the initiative are the U.S....
(Date:11/21/2008)...eholders Intend To Vigorously Protect Investment A..., Nov. 21 Dr. Stephen J...amendment to their Schedule 13D with the U.S. Secu...sly filed a 13D disclosing ownership of 11.4% of L...77 LasikPlus fixed-site laser vision correction ce...
Breaking Medicine News(10 mins):Health News:Long-Term Erythromycin Cut COPD Complications 2Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research Extends to Panama 2Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research Extends to Panama 3Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 2Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 3Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 4Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 5Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 6Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 7
...deo, designed to increase emotional well-being and...creased knowledge but did not change behavior or e...y succeeded in increasing patients' knowledge of m...ty of adaptive devices and techniques, it did not ...
...tion to treat kleptomania has failed to find any c...stealing disorder,// according to researchers at t... results leave open the possibility that some medi..., may still be an effective treatment for certain ...
...hat as many as 25 percent of all patients admitted...monia, which can be fatal. // Ventilator-associate...ospital, and studies have shown that this infectio...and double the length of stay of the patient in th...
... Wisconsin is running a pioneering trial of using ...sults of which have //been "encouraging". Amish R... his team of cardiologists began their trial on Ma...cells for cardiac disease) works, it could revolut...
Other Medicine News:Health News:Educational Video Increases Knowledge but Not Behavior 2Health News:Educational Video Increases Knowledge but Not Behavior 3Health News:Study Finds No Conclusive Benefit from Treating Kleptomania 2Health News:Patients Own Dental Plaque may Cause Ventilator-associated Pneumonia 2
(Date:11/20/2008)...Calif., Nov. 20 Bionovo,...l present results from the Phase 1B,clinical tria...atic breast,cancer, BZL101, at the Society for In...ce in Atlanta, Georgia. The Company,s oral presen... will be presented as a part of the Best of the,S...
(Date:11/20/2008)...ass., Nov. 20 Radius Health ("Radi...nal $15 million to its second institutional financ... $82.5 million and the total amount raised since t...ting institutional investors participated in the f... including MPM Capital, The Wellcome Trust, Health...
(Date:11/20/2008)... 20 PAREXEL Internationa...biopharmaceutical services provider, today announc...rovide regulatory consulting and clinical research...e, PAREXEL now has locations throughout five impor...hich also include Argentina, Brazil, Chile, and Me...
(Date:11/19/2008)...O, Nov. 19 Posit Science Corporati...the Society for Neuroscience,Annual Conference in...e,training may benefit Baby Boomers. The compute...m (TM) uses adaptive exercises that target auditor...ed to drive generalized,improvements in cognition...
Breaking Medicine Technology:Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 2Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 3Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 5Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million 2PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 2PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 3PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 4New Evidence That Brain-Plasticity Based Training has Broad Impact: Improved Cognition in Boomers, Improved Motor Control in Older Adults 2Breast cancer more aggressive among obese women 14374 1Breast cancer more aggressive among obese women 14374 2News from the March 2008 American Physical Society Meeting 3967 1News from the March 2008 American Physical Society Meeting 3967 2News from the March 2008 American Physical Society Meeting 3967 3News from the March 2008 American Physical Society Meeting 3967 4News from the March 2008 American Physical Society Meeting 3967 5Genmab and PDL BioPharma Close Sale of Antibody Manufacturing Facility 3963 1Genmab and PDL BioPharma Close Sale of Antibody Manufacturing Facility 3963 2Quaker 28R 29 Life 28R 29 Cereal Partners with Actress and Mom Holly Robinson Peete to Inspire Moms to Make Their Best Days Happen 14371 1Quaker 28R 29 Life 28R 29 Cereal Partners with Actress and Mom Holly Robinson Peete to Inspire Moms to Make Their Best Days Happen 14371 2Quaker 28R 29 Life 28R 29 Cereal Partners with Actress and Mom Holly Robinson Peete to Inspire Moms to Make Their Best Days Happen 14371 3
For the qualitative detection of single and multiple drugs and drug metabolites in human urine
For the qualitative detection of single and multiple drugs and drug metabolites in human urine
For the qualitative detection of cardiac troponin I (cTnl) in human whole blood and serum specimens
For the qualitative differential detection of circulating Plasmodium falciparum (P.f) antigen and an antigen that is common to all four species of malaria:plasmodium falciparum (P.f), plasmodium viv
Medicine Products: